Application Sponsors
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | EQ 7.5MG BASE | 0 | DARIFENACIN HYDROBROMIDE | DARIFENACIN HYDROBROMIDE |
002 | TABLET, EXTENDED RELEASE;ORAL | EQ 15MG BASE | 0 | DARIFENACIN HYDROBROMIDE | DARIFENACIN HYDROBROMIDE |
FDA Submissions
Submissions Property Types
CDER Filings
ANCHEN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 91190
[companyName] => ANCHEN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"DARIFENACIN HYDROBROMIDE","activeIngredients":"DARIFENACIN HYDROBROMIDE","strength":"EQ 7.5MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"DARIFENACIN HYDROBROMIDE","activeIngredients":"DARIFENACIN HYDROBROMIDE","strength":"EQ 15MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"DARIFENACIN HYDROBROMIDE","submission":"DARIFENACIN HYDROBROMIDE","actionType":"EQ 7.5MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"DARIFENACIN HYDROBROMIDE","submission":"DARIFENACIN HYDROBROMIDE","actionType":"EQ 15MG BASE","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)